In last trading session, AIM ImmunoTech Inc (AMEX:AIM) saw 0.35 million shares changing hands with its beta currently measuring 0.36. Company’s recent per share price level of $0.14 trading at $0.0 or -3.15% at ring of the bell on the day assigns it a market valuation of $9.51M. That closing price of AIM’s stock is at a discount of -342.86% from its 52-week high price of $0.62 and is indicating a premium of 14.29% from its 52-week low price of $0.12.
For AIM ImmunoTech Inc (AIM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.09 in the current quarter.
AIM ImmunoTech Inc (AMEX:AIM) trade information
Upright in the red during last session for losing -3.15%, in the last five days AIM remained trading in the red while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $0.14 price level, adding 6.67% to its value on the day. AIM ImmunoTech Inc’s shares saw a change of -30.15% in year-to-date performance and have moved -0.22% in past 5-day. AIM ImmunoTech Inc (AMEX:AIM) showed a performance of -38.53% in past 30-days.
AIM ImmunoTech Inc (AIM) estimates and forecasts
This year revenue growth is estimated to fall -0.99% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 100k for the same. Company posted 65k and 40k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 42.86% during past 5 years.
AIM ImmunoTech Inc (AMEX:AIM)’s Major holders
ARMISTICE CAPITAL, LLC is the top institutional holder at AIM for having 4.08 million shares of worth $1.52 million. And as of 2024-06-30, it was holding 7.718 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.99 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.021 of outstanding shares, having a total worth of $0.74 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.31 shares of worth $0.18 million or 1.91% of the total outstanding shares. The later fund manager was in possession of 620.23 shares on Sep 30, 2024 , making its stake of worth around $85777.0 in the company or a holder of 0.90% of company’s stock.
